- Home
- NL vs RNAC Comparison
NL vs RNAC Comparison
Compare NL & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NL
- RNAC
- Stock Information
- Founded
- NL 1891
- RNAC 2007
- Country
- NL United States
- RNAC United States
- Employees
- NL N/A
- RNAC N/A
- Industry
- NL Major Chemicals
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- NL Industrials
- RNAC Health Care
- Exchange
- NL Nasdaq
- RNAC Nasdaq
- Market Cap
- NL 320.5M
- RNAC 276.3M
- IPO Year
- NL N/A
- RNAC 2016
- Fundamental
- Price
- NL $6.52
- RNAC $10.05
- Analyst Decision
- NL Sell
- RNAC Strong Buy
- Analyst Count
- NL 1
- RNAC 4
- Target Price
- NL $6.00
- RNAC $40.00
- AVG Volume (30 Days)
- NL 27.5K
- RNAC 48.4K
- Earning Date
- NL 08-06-2025
- RNAC 08-07-2025
- Dividend Yield
- NL 5.50%
- RNAC N/A
- EPS Growth
- NL 141.37
- RNAC N/A
- EPS
- NL 1.10
- RNAC N/A
- Revenue
- NL $152,721,000.00
- RNAC $1,026,000.00
- Revenue This Year
- NL $15.75
- RNAC N/A
- Revenue Next Year
- NL $2.44
- RNAC N/A
- P/E Ratio
- NL $5.96
- RNAC N/A
- Revenue Growth
- NL N/A
- RNAC N/A
- 52 Week Low
- NL $5.29
- RNAC $8.46
- 52 Week High
- NL $9.42
- RNAC $26.50
- Technical
- Relative Strength Index (RSI)
- NL 51.90
- RNAC 34.71
- Support Level
- NL $6.30
- RNAC $10.50
- Resistance Level
- NL $6.82
- RNAC $11.80
- Average True Range (ATR)
- NL 0.33
- RNAC 0.56
- MACD
- NL 0.04
- RNAC -0.11
- Stochastic Oscillator
- NL 60.00
- RNAC 0.45
About NL NL Industries Inc.
NL Industries Inc is a holding company that operates in the component products industry. Through its subsidiary, it manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. It also produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.